Stifel Nicolaus Keeps Their Buy Rating on Altimmune (ALT)
Stifel Nicolaus analyst Annabel Samimy maintained a Buy rating on Altimmune (ALT – Research Report) today and set a price target of $18.00. The ...
Stifel Nicolaus Reaffirms Their Buy Rating on Sylogist (SYZ)
In a report released today, Suthan Sukumar from Stifel Nicolaus maintained a Buy rating on Sylogist (SYZ – Research Report), with a price ...
Financial Planning18h
Stifel hammered with punitive damages in $133M arbitration award
For the second time in about two weeks, a FINRA arbitration panel has cited state statutes to slap a wealth management firm ...
Wall Street Regulator Orders Stifel to Pay $133 Million in Structured-Notes Case
The largest arbitration award granted to retail clients is the third ruling against Stifel involving advisor Chuck Roberts. More cases are in the pipeline.
Big month of major sports events begins Thursday
The weather is warming up, but there’s still an icy chill in St. Louis as a monthlong stretch of major hockey events begins ...